GreenWay DNA is revolutionizing wellness! A Key to unlocking the potential of cannabis is understanding how genetics inform our body’s innate, unique responses to cannabinoids. Greenway’s patent-pending DNA test uses your saliva to reveal the needs of your Endocannabinoid system. Greenway then couples your individual genetic makeup with their closed-loop, smart device enabled metered dosing vape devices to provide end-to-end, AI-informed treatment recommendations, giving you a precise starting point for CBD and/or THC dosing and a smart device with which to monitor, adjust, and deliver your treatment.
Through precision, smart-enabled dosage delivery, published content, helpful resource guides, community engagement and gamification, and exemplary patient support, Greenway will become the leading global wellness brand leveraging precision cannabinoid medicine and advanced data analytics to improve health and wellbeing.
Join us to hear from Gregg Steinberg, co-founder, CEO, and Board member of Greenway DNA for an in-depth discussion on how to empower your path to wellness.